In summary, these findings may reveal that glucagon-induced acetylation of different energy-sensing factors has diverse effects on tumorigenesis and hepatocarcinogenesis, and also provides potential strategies for the treatment of liver cancer. This evidence concerns the gene GCG and liver cancer.